ライフサイエンスコーパス: cadaveric renal transplantation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 , thereby, improve the overall efficiency of cadaveric renal transplantation.

2 th ESRD face barriers in being activated for cadaveric renal transplantation.

3 ritoneal (PD) dialysis patients who received cadaveric renal transplantation.

4 d systemic reactions beginning 10 days after cadaveric renal transplantation.

5 or sociodemographic differences in access to cadaveric renal transplantation.

6 raft rejection in three controlled trials of cadaveric renal transplantation.

7 a recipient contracting HCV hepatitis after cadaveric renal transplantation.

8 r prolong delayed graft function (DGF) after cadaveric renal transplantation.

9 olate mofetil (CI-free regimen) in high-risk cadaveric renal transplantation.

10 thnic minority's access to and outcome after cadaveric renal transplantation.

11 matches between donor and recipient in first cadaveric renal transplantations.

12 creased patient and allograft survival after cadaveric renal transplantation and that other factors b

13 olimus (n=205) or cyclosporine (n=207) after cadaveric renal transplantation and were followed for 1

14 We conclude that cadaveric renal transplantation can be performed using c

15 The use of older donors for cadaveric renal transplantation (CRT) remains controvers

16 s with chronic hepatitis C virus prohibiting cadaveric renal transplantation (CRT).

17 In cadaveric renal transplantation, delayed graft function

18 a case of ureteral obstruction 5 years after cadaveric renal transplantation due to an ovarian tumor.

19 Two HCV-infected patients underwent cadaveric renal transplantation for end-stage renal dise

20 reviewed to identify all patients undergoing cadaveric renal transplantation in the United States fro

21 Cadaveric renal transplantation is a cost-saving treatme

22 he use of expanded criteria donors (ECDs) in cadaveric renal transplantation is increasing in the US.

23 improvement in survival compared to solitary cadaveric renal transplantation or dialysis.

24 arious factors affect the outcome of primary cadaveric renal transplantation, particularly the age of

25 hese bioflavonoids improve early outcomes in cadaveric renal transplantation, possibly through HO-1 i

26 Cadaveric renal transplantation rates differ greatly by

27 the current system for listing patients for cadaveric renal transplantation, using univariate and mu

28 The median waiting times to cadaveric renal transplantation were also significantly

29 atients aged 18 years or older who underwent cadaveric renal transplantation without another simultan

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。